<p>(A) Dose-response effect of nLDL, oxLDL and oxPAPC (0-100 µg/ml) and (B) dose-response effect of lysoPC (0-50 µM) on mRNA expression of Lp-PLA2 after incubation with PBMC for 6 h. Normalized gene expression levels were given as the ratio between the mean value for Lp-PLA2 gene and that for the beta-actin in each sample. Data represent the mean±SD of measurements performed in triplicate in four different occasions. *P<0.01 versus basal, †P<0.01 versus oxPAPC.</p
<p>Real-time PCR analysis showing SERCA2 (A), RyR2 (B), IP3-RI (C) and IP3-RIII mRNA expression leve...
<p>mRNA (A–C) was analysed by quantitative Real-Time PCR. Normalised gene expression levels were giv...
<div><p>Oxidized phospholipids (oxPLs) are components of oxidized LDL (oxLDL). It is known that oxLD...
<p>Effect of increasing concentrations (0-50 µM) of lysoPC on (A) biglycan and on (B) versican mRNA ...
<p>(<b>A</b>) – Western blots for Lipoxygenases-12, lipoxygenase -15-2 and P22<sup>phox</sup> and P4...
<p>(<b>A</b>) hADSCs were treated with or without LPS (50 ng/ml), immediately followed by LPLI (8 J/...
<p>A: Post-heparin LPL enzyme activity assayed as described earlier. B: LPL activity of various tiss...
<p>A, B: effects of different concentration of oxLDL on let-7a and let-7b expression; C, D: effects ...
<p>Effect of increasing concentrations (0-50 µM) of lysoPC on biglycan protein expression after incu...
<p>AngII dose-response of LPL expression in adipose tissues. VAT (A1, B1, and C1) or SAT (A2, B2, an...
<p>(<b>A</b>) – Western blots for phospho-IκBα and p44/42 MAPK with corresponding graphs depicting r...
(A) mRNA expression of Lp-PLA2 in the plaques of the vehicle, scrambled, Lp-PLA2 RNAi, YKL-40 RNAi, ...
Gene expression as assayed by quantitative PCR on RNA from ARPE19 treated with 50 μg/mL of native-LD...
Dose-response effect of native (non-oxidized) LDL on the quantities of oxidized LDL (A), MCP-1, IL-1...
<p><b>A</b>: The figure shows the result of Western blot analysis for β-actin, NHE 1, 2 and 3, from ...
<p>Real-time PCR analysis showing SERCA2 (A), RyR2 (B), IP3-RI (C) and IP3-RIII mRNA expression leve...
<p>mRNA (A–C) was analysed by quantitative Real-Time PCR. Normalised gene expression levels were giv...
<div><p>Oxidized phospholipids (oxPLs) are components of oxidized LDL (oxLDL). It is known that oxLD...
<p>Effect of increasing concentrations (0-50 µM) of lysoPC on (A) biglycan and on (B) versican mRNA ...
<p>(<b>A</b>) – Western blots for Lipoxygenases-12, lipoxygenase -15-2 and P22<sup>phox</sup> and P4...
<p>(<b>A</b>) hADSCs were treated with or without LPS (50 ng/ml), immediately followed by LPLI (8 J/...
<p>A: Post-heparin LPL enzyme activity assayed as described earlier. B: LPL activity of various tiss...
<p>A, B: effects of different concentration of oxLDL on let-7a and let-7b expression; C, D: effects ...
<p>Effect of increasing concentrations (0-50 µM) of lysoPC on biglycan protein expression after incu...
<p>AngII dose-response of LPL expression in adipose tissues. VAT (A1, B1, and C1) or SAT (A2, B2, an...
<p>(<b>A</b>) – Western blots for phospho-IκBα and p44/42 MAPK with corresponding graphs depicting r...
(A) mRNA expression of Lp-PLA2 in the plaques of the vehicle, scrambled, Lp-PLA2 RNAi, YKL-40 RNAi, ...
Gene expression as assayed by quantitative PCR on RNA from ARPE19 treated with 50 μg/mL of native-LD...
Dose-response effect of native (non-oxidized) LDL on the quantities of oxidized LDL (A), MCP-1, IL-1...
<p><b>A</b>: The figure shows the result of Western blot analysis for β-actin, NHE 1, 2 and 3, from ...
<p>Real-time PCR analysis showing SERCA2 (A), RyR2 (B), IP3-RI (C) and IP3-RIII mRNA expression leve...
<p>mRNA (A–C) was analysed by quantitative Real-Time PCR. Normalised gene expression levels were giv...
<div><p>Oxidized phospholipids (oxPLs) are components of oxidized LDL (oxLDL). It is known that oxLD...